Evolutionary Genomics, Inc.
Evolutionary Genomics, Inc. (FNAM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · FNAM · as of Jun 9, 2026
Key Statistics
Explore Evolutionary Genomics, Inc. Data
fnam stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
fnam competitorsFNAM
CLABF
DOSEF
ENZN
HLYK
LIFDStock Performance
Full HistoryAbout Evolutionary Genomics, Inc.
Evolutionary Genomics, Inc. including its affiliated businesses, focuses on investigating and identifying beneficial genes found in humans, various animal species, and commercial agricultural crops. …
what is evolutionary genomics, inc. · fnam stock overview · evolutionary genomics, inc. company profile · who is evolutionary genomics, inc. ceo · fnam OTC · evolutionary genomics, inc. headquarters · evolutionary genomics, inc. business segments
About Stock Overview & Key Data
Evolutionary Genomics, Inc. (FNAM) is a Healthcare company in the Biotechnology industry, listed on OTC since May 15, 2012. As of the latest trading session, FNAM stock price is $0.00, with a market capitalization of $1,331. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2022, Evolutionary Genomics, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Evolutionary Genomics, Inc. (FNAM) stock price is $0.00. The stock is traded on OTC under the ticker symbol FNAM. The 52-week range is $0.00 – $0.45.